查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2080357

體外診斷市場：2026-2032年全球市場預測（按產品、檢測類型、檢體類型、工作流程自動化、應用、最終用戶和患者群體分類）

In-Vitro Diagnostics Market by Offering, Test Type, Specimen, Workflow Automation, Application, End User, Patient Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，體外診斷市場規模將達到 1,751.4 億美元，複合年成長率為 6.87%。

主要市場統計數據
基準年 2025 1099.9億美元
預計年份：2026年 1173.1億美元
預測年份 2032 1751.4億美元
複合年成長率 (%) 6.87%

體外診斷（IVD）是現代醫學的核心，它透過檢體血液、組織、唾液和尿液等樣本，實現疾病檢測、治療選擇、患者監測、血液篩檢和公共衛生監測。此領域涵蓋的工作流程包括臨床化學、免疫檢測、血液學、分子診斷、微生物學、即時檢測、伴隨診斷和檢查室自建檢測（LDT）。

行業趨勢檢驗表明，市場對更快、更分散、更精準的診斷方法的需求持續存在。世界衛生組織（WHO）已將診斷技術視為全民健康覆蓋（UHC）的關鍵要素，而美國食品藥物管理局（FDA）和歐盟委員會等監管機構也不斷加強對分析有效性、臨床表現、網路安全和上市後證據的監管。隨著醫療保健系統向價值導向醫療模式轉型，體外診斷（IVD）製造商、參考實驗室、醫院和數位健康開發公司正在競相提升診斷產品的準確性、縮短結果報告時間、互通性並提高其在實際臨床應用中的效用。

體外診斷產業的變革

體外診斷（IVD）產業的模式正因去中心化、自動化、分子檢測以及從「以產量為導向」到「以臨床應用價值為導向」的轉變而重塑。雖然新冠疫情加速了對PCR、抗原和快速檢測能力的投資，但這些基礎設施目前正被重新導向至呼吸道病原體檢測、抗生素抗藥性檢測、腫瘤學、女性健康和慢性病監測等領域。

人工智慧在體外診斷的累積影響

人工智慧 (AI) 正從一項獨立功能發展成為貫穿整個體外診斷 (IVD) 價值鏈的實用環節。 AI 支援數位病理學和血液學中的影像分析、分子和蛋白質組學數據中的模式識別、預測性品管、自動結果解讀，以及為分診和復檢提供決策支援。這些應用可以利用具有代表性的臨床資料集檢驗，從而減輕人工審核的負擔並提高結果的可重複性。

主要體外診斷市場的關鍵區域洞察

北美憑藉其先進的檢查室網路、完善的保險報銷體系、積極的FDA核准流程以及分子診斷、腫瘤檢測和即時檢驗（POC）平台的高普及率，仍然是體外診斷（IVD）的高價值地區。美國透過投資重點發展參考實驗室、大學附屬醫院和診斷技術來推動創新，而加拿大則強調公共資助的檢測服務、品管的省級檢測系統以及標準化的臨床路徑。

關鍵區域洞察：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

隨著印尼、越南、泰國、馬來西亞、菲律賓和新加坡等國的醫院容量、私人診斷網路​​和感染疾病監測能力的提升，東協地區的需求正在不斷成長。由於部分東協市場對採購價格的敏感度仍然很高，因此，擴充性、方便用戶使用且服務完善的體外診斷平台對於該地區的廣泛應用至關重要。

主要國家影響體外診斷需求的趨勢

美國正引領體外診斷（IVD）創新，這主要得益於對分子診斷、癌症伴隨診斷、分散式檢查和高通量檢查室自動化的強勁需求。加拿大優先考慮品質、公平取得和省級採購效率，而墨西哥則受益於私人實驗室的成長以及與近岸外包相關的醫療保健投資。巴西是拉丁美洲最大的醫療保健市場，其需求涵蓋感染疾病、慢性病、血液篩檢和醫院診斷等領域。

為體外診斷產業領導者提供的實用建議

行業領導者應優先考慮提供證據，將分析績效與臨床結果、報銷價值和工作流程效率聯繫起來。能夠加速診斷速度、減少重複檢測、改善治療方案、提高抗生素使用效率或增強人群篩檢能力的產品，將為保險公司、醫院、實驗室和公共衛生採購人員帶來顯著優勢。

調查方法和證據

本執行分析是基於來自檢驗的公共和機構資訊來源的二手資訊來源，包括監管機構、衛生組織、標準化機構、同行評審文獻、臨床實驗室指南、公共採購指標和國家衛生政策文件。參考的資訊來源包括世界衛生組織、美國食品藥物管理局、歐盟委員會、各國衛生署、經合組織衛生資料和經認可的臨床實驗室醫學協會。

結論：體外診斷的未來

體外診斷市場正邁向一個更加互聯互通、以證據為基礎且地理分佈更加多元化的階段。人口老化、感染疾病監測、精準醫療、慢性病管理、抗生素抗藥性監測以及在中心檢查室和即時檢測（PoC）環境中快速進行臨床決策的需求，都是推動市場需求成長的主要因素。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 體外診斷市場：依產品/服務分類

  • 裝置
    • 分析器
    • 自動化系統
    • 定序裝置
  • 試劑和試劑盒
  • 服務
    • 安裝和驗證服務
    • 培訓和諮詢服務
    • 維護和支援服務
  • 軟體和資訊技術
    • 實驗室資訊系統
    • 數據分析與解釋軟體

第8章 體外診斷市場：依檢測類型分類

  • 臨床化學
    • 血液分析
    • 電解質面板
    • 肝功能檢查
    • 甲狀腺功能檢查項目
    • 尿液檢查
  • 血液學
  • 免疫測量
  • 微生物學
  • 分子診斷

第9章 體外診斷市場：依檢體類型分類

  • 血液、血清、血漿
  • 唾液
  • 組織樣本
  • 尿

第10章 體外診斷市場：依工作流程自動化分類

  • 人工檢查
  • 半自動系統
  • 全自動系統
  • 整合工作單元
  • 全面實驗室自動化

第11章 體外診斷市場：依應用分類

  • 自體免疫疾病
  • 癌症篩檢
  • 心臟監測
  • 糖尿病管理
  • 基因檢測
  • 傳染病檢查

第12章 體外診斷市場：依最終用戶分類

  • 學術和研究機構
  • 診斷檢查室
  • 醫院
  • 即時檢測中心

第13章 體外診斷市場：依病患類型分類

  • 成人
  • 兒童

第14章 體外診斷市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 體外診斷市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 體外診斷市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Abbott Laboratories
  • Agappe Diagnostics Ltd.
  • Agilent Technologies, Inc.
  • ARKRAY Inc.
  • Asahi Kasei Corporation
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • DiaSorin SpA
  • Edan Instruments, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • Grifols SA
  • HiMedia Laboratories Pvt. Ltd.
  • Hitachi High-Tech Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • J Mitra & Co. Pvt. Ltd.
  • KAINOS Laboratories, Inc.
  • Kyowa Medex Co., Ltd.
  • Labcorp Holdings Inc.
  • Meril Diagnostics Pvt. Ltd.
  • Nihon Kohden Corporation
  • PerkinElmer, Inc.
  • QIAGEN NV
  • QuidelOrtho Corporation
  • Revvity, Inc.
  • Seegene, Inc.
  • Sekisui Medical Co., Ltd.
  • Shanghai Kehua Bio-engineering Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Transasia Bio-Medicals Ltd.
  • Werfen, SA
Product Code: MRR-434CCDA04D33

The In-Vitro Diagnostics Market is projected to grow by USD 175.14 billion at a CAGR of 6.87% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 109.99 billion
Estimated Year [2026] USD 117.31 billion
Forecast Year [2032] USD 175.14 billion
CAGR (%) 6.87%

In-vitro diagnostics (IVD) sit at the center of modern healthcare, enabling disease detection, therapy selection, patient monitoring, blood screening, and public health surveillance through tests performed on specimens such as blood, tissue, saliva, and urine. The sector spans clinical chemistry, immunoassays, hematology, molecular diagnostics, microbiology, point-of-care testing, companion diagnostics, and laboratory-developed test workflows.

Verified industry signals show sustained demand for faster, more decentralized, and more precise diagnostics. The World Health Organization recognizes diagnostics as essential to universal health coverage, while regulators such as the U.S. FDA and the European Commission continue to strengthen oversight for analytical validity, clinical performance, cybersecurity, and post-market evidence. As healthcare systems shift toward value-based care, IVD manufacturers, reference laboratories, hospitals, and digital health developers are competing on accuracy, turnaround time, interoperability, and real-world clinical utility.

Transformative Shifts in the IVD Landscape

The IVD landscape is being reshaped by decentralization, automation, molecular testing, and the move from volume-based testing to clinically actionable insights. COVID-19 accelerated investment in PCR, antigen, and rapid testing capacity; that infrastructure is now being redirected toward respiratory panels, antimicrobial resistance, oncology, women's health, and chronic disease monitoring.

Regulatory transformation is equally important. The EU In Vitro Diagnostic Medical Devices Regulation (IVDR) has raised requirements for clinical evidence and notified body review, while U.S. oversight continues to evolve around laboratory-developed tests and software-enabled diagnostics. At the same time, laboratories are adopting total lab automation, sample-to-answer platforms, remote quality management, and connected point-of-care devices to reduce labor constraints and improve consistency.

Cumulative Impact of Artificial Intelligence on IVD

Artificial intelligence is becoming a practical layer across the IVD value chain rather than a standalone feature. AI supports image analysis in digital pathology and hematology, pattern recognition in molecular and proteomic data, predictive quality control, automated result interpretation, and decision support for triage or reflex testing. These applications can reduce manual review burden and improve reproducibility when validated against representative clinical datasets.

The cumulative impact of AI depends on governance. Successful adoption requires explainability, bias monitoring, cybersecurity, locked and adaptive algorithm controls, and integration with laboratory information systems and electronic health records. Regulators have authorized a growing number of AI-enabled medical devices across healthcare, signaling a clearer pathway for validated clinical AI; however, IVD leaders must prove analytical performance, clinical relevance, and continuous post-market monitoring before scaling.

Key Regional Insights Across Major IVD Markets

North America remains a high-value IVD region due to advanced laboratory networks, established reimbursement infrastructure, active FDA pathways, and high adoption of molecular diagnostics, oncology testing, and point-of-care platforms. The United States anchors innovation through reference laboratories, academic medical centers, and diagnostics-focused investment, while Canada emphasizes publicly funded testing access, quality-managed provincial laboratory systems, and standardized clinical pathways.

Europe is defined by IVDR-driven compliance, strong hospital laboratory infrastructure, and mature demand for companion diagnostics, infectious disease testing, and chronic disease monitoring. Asia-Pacific is a highly dynamic opportunity pool, supported by China's healthcare modernization and domestic IVD manufacturing, India's expanding diagnostic access, Japan's aging population, South Korea's molecular testing capability, and Australia's high-standard clinical pathology ecosystem.

Latin America, the Middle East, and Africa are increasingly important for access-driven IVD expansion. Brazil and Mexico lead Latin American demand through hospital diagnostics, private laboratory networks, and infectious disease testing needs. GCC countries in the Middle East are investing in hospital modernization, genomic medicine, and national screening programs, while African markets are prioritizing infectious disease diagnostics, decentralized testing, blood safety, and donor-supported public health programs aligned with WHO essential diagnostics priorities.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN demand is expanding as Indonesia, Vietnam, Thailand, Malaysia, the Philippines, and Singapore improve hospital capacity, private diagnostics networks, and infectious disease surveillance. Procurement sensitivity remains high across several ASEAN markets, making scalable, easy-to-use, and service-supported IVD platforms essential for regional adoption.

The European Union is shaped by harmonized but more demanding IVDR requirements, creating opportunities for organizations with strong clinical evidence, quality systems, and notified body readiness. GCC countries are adopting advanced diagnostics to support national health transformation agendas, preventive screening, and specialist care expansion, while BRICS economies combine large patient populations with rising domestic manufacturing, public health testing needs, and growing molecular diagnostics demand.

G7 markets remain the benchmark for premium IVD innovation, reimbursement sophistication, companion diagnostic adoption, and advanced laboratory automation. NATO-aligned healthcare systems, particularly in Europe and North America, are also prioritizing resilient diagnostic supply chains, laboratory surge capacity, biosurveillance, and biosecurity-linked readiness after pandemic-era disruptions.

Key Country Insights Shaping IVD Demand

The United States leads IVD innovation with strong demand for molecular diagnostics, oncology companion diagnostics, decentralized testing, and high-throughput laboratory automation. Canada prioritizes quality, equitable access, and provincial procurement efficiency, while Mexico benefits from private laboratory growth and nearshoring-linked healthcare investment. Brazil is Latin America's largest healthcare market, with demand spanning infectious disease, chronic disease, blood screening, and hospital-based diagnostics.

In Europe, the United Kingdom remains influential in genomics, infectious disease surveillance, and National Health Service laboratory modernization. Germany and France are major IVD adopters due to strong clinical infrastructure, reimbursement depth, and specialist laboratory capacity, while Italy and Spain show rising demand for chronic disease, oncology, and hospital diagnostics. Russia continues to emphasize domestic capability, essential testing access, and supply chain localization amid geopolitical constraints.

China is scaling domestic IVD manufacturing, molecular testing, and hospital diagnostics, while India is expanding affordable diagnostics through private chains, public health programs, and broader access to laboratory services. Japan's aging population supports oncology, cardiovascular, and chronic disease testing; South Korea is strong in molecular diagnostics, digital health integration, and export-oriented innovation; and Australia maintains a high-quality pathology market with demand for automated, accredited testing and decentralized access across large geographies.

Actionable Recommendations for IVD Industry Leaders

Industry leaders should prioritize evidence generation that connects analytical performance to clinical outcomes, reimbursement value, and workflow efficiency. Products that demonstrate faster diagnosis, reduced repeat testing, improved therapy selection, better antimicrobial stewardship, or stronger population screening performance are better positioned with payers, hospitals, laboratories, and public health buyers.

Companies should also invest in regulatory readiness, AI governance, cybersecurity, and supply chain resilience. Building IVDR-compliant technical documentation, scalable quality systems, multi-region clinical validation, and interoperable digital connectivity will reduce commercialization risk. Strategic partnerships with hospitals, reference laboratories, biopharma firms, public health agencies, and regional distributors can accelerate adoption while improving local service coverage.

Research Methodology and Evidence Base

This executive analysis is built on secondary research from verified public and institutional sources, including regulatory authorities, health agencies, standards organizations, peer-reviewed literature, clinical laboratory guidance, public procurement indicators, and national healthcare policy documents. Sources considered include the WHO, U.S. FDA, European Commission, national health ministries, OECD health data, and recognized laboratory medicine associations.

The methodology triangulates regulatory developments, technology adoption patterns, disease burden indicators, healthcare infrastructure maturity, reimbursement dynamics, quality requirements, and regional access factors. Insights are validated through consistency checks across multiple source categories and are written to support strategic planning, and executive decision-making in the global in-vitro diagnostics market.

Conclusion: The Future of In-Vitro Diagnostics

The in-vitro diagnostics market is entering a more connected, evidence-driven, and regionally diversified phase. Demand is supported by aging populations, infectious disease surveillance, precision medicine, chronic disease management, antimicrobial resistance monitoring, and the need for faster clinical decisions across centralized laboratories and point-of-care settings.

Winning organizations will combine scientific credibility with operational scalability. IVD developers and laboratory stakeholders that align innovation with regulatory evidence, digital interoperability, AI governance, cybersecurity, and localized access strategies will be best positioned to support safer, faster, and more equitable healthcare delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. In-Vitro Diagnostics Market, by Offering

  • 7.1. Instruments
    • 7.1.1. Analyzers
    • 7.1.2. Automation Systems
    • 7.1.3. Sequencing Instrument
  • 7.2. Reagents & Kits
  • 7.3. Services
    • 7.3.1. Installation & Validation Services
    • 7.3.2. Training & Consulting Services
    • 7.3.3. Maintenance & Support Services
  • 7.4. Software & Informatics
    • 7.4.1. Laboratory Information Systems
    • 7.4.2. Data Analytics & Interpretation Software

8. In-Vitro Diagnostics Market, by Test Type

  • 8.1. Clinical Chemistry
    • 8.1.1. Blood Analysis
    • 8.1.2. Electrolyte Panel
    • 8.1.3. Liver Panel
    • 8.1.4. Thyroid Function Panel
    • 8.1.5. Urine Analysis
  • 8.2. Hematology
  • 8.3. Immunoassays
  • 8.4. Microbiology
  • 8.5. Molecular Diagnostics

9. In-Vitro Diagnostics Market, by Specimen

  • 9.1. Blood, Serum & Plasma
  • 9.2. Saliva
  • 9.3. Tissue Samples
  • 9.4. Urine

10. In-Vitro Diagnostics Market, by Workflow Automation

  • 10.1. Manual Testing
  • 10.2. Semi Automated Systems
  • 10.3. Fully Automated Systems
  • 10.4. Integrated Workcells
  • 10.5. Total Laboratory Automation

11. In-Vitro Diagnostics Market, by Application

  • 11.1. Autoimmune Diseases
  • 11.2. Cancer Detection
  • 11.3. Cardiac Monitoring
  • 11.4. Diabetes Management
  • 11.5. Genetic Testing
  • 11.6. Infectious Disease Testing

12. In-Vitro Diagnostics Market, by End User

  • 12.1. Academic & Research Centers
  • 12.2. Diagnostic Laboratories
  • 12.3. Hospitals
  • 12.4. Point-Of-Care Testing Centers

13. In-Vitro Diagnostics Market, by Patient Type

  • 13.1. Adults
  • 13.2. Pediatrics

14. In-Vitro Diagnostics Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. In-Vitro Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. In-Vitro Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Abbott Laboratories
  • 18.2. Agappe Diagnostics Ltd.
  • 18.3. Agilent Technologies, Inc.
  • 18.4. ARKRAY Inc.
  • 18.5. Asahi Kasei Corporation
  • 18.6. Becton, Dickinson and Company
  • 18.7. Bio-Rad Laboratories, Inc.
  • 18.8. bioMerieux SA
  • 18.9. Danaher Corporation
  • 18.10. DiaSorin S.p.A.
  • 18.11. Edan Instruments, Inc.
  • 18.12. Eurofins Scientific SE
  • 18.13. F. Hoffmann-La Roche Ltd.
  • 18.14. FUJIFILM Holdings Corporation
  • 18.15. Grifols S.A.
  • 18.16. HiMedia Laboratories Pvt. Ltd.
  • 18.17. Hitachi High-Tech Corporation
  • 18.18. Hologic, Inc.
  • 18.19. Illumina, Inc.
  • 18.20. J Mitra & Co. Pvt. Ltd.
  • 18.21. KAINOS Laboratories, Inc.
  • 18.22. Kyowa Medex Co., Ltd.
  • 18.23. Labcorp Holdings Inc.
  • 18.24. Meril Diagnostics Pvt. Ltd.
  • 18.25. Nihon Kohden Corporation
  • 18.26. PerkinElmer, Inc.
  • 18.27. QIAGEN N.V.
  • 18.28. QuidelOrtho Corporation
  • 18.29. Revvity, Inc.
  • 18.30. Seegene, Inc.
  • 18.31. Sekisui Medical Co., Ltd.
  • 18.32. Shanghai Kehua Bio-engineering Co., Ltd.
  • 18.33. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.34. Siemens AG
  • 18.35. Sysmex Corporation
  • 18.36. Thermo Fisher Scientific, Inc.
  • 18.37. Tosoh Corporation
  • 18.38. Transasia Bio-Medicals Ltd.
  • 18.39. Werfen, S.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANALYZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANALYZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SEQUENCING INSTRUMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SEQUENCING INSTRUMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SEQUENCING INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INSTALLATION & VALIDATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INSTALLATION & VALIDATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INSTALLATION & VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TRAINING & CONSULTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TRAINING & CONSULTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TRAINING & CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAINTENANCE & SUPPORT SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SOFTWARE & INFORMATICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LABORATORY INFORMATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DATA ANALYTICS & INTERPRETATION SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DATA ANALYTICS & INTERPRETATION SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DATA ANALYTICS & INTERPRETATION SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ELECTROLYTE PANEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ELECTROLYTE PANEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ELECTROLYTE PANEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIVER PANEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LIVER PANEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LIVER PANEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL THYROID FUNCTION PANEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL THYROID FUNCTION PANEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL THYROID FUNCTION PANEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL URINE ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL URINE ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL URINE ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEMATOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEMATOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IMMUNOASSAYS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MICROBIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD, SERUM & PLASMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD, SERUM & PLASMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD, SERUM & PLASMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SALIVA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SALIVA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SALIVA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TISSUE SAMPLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TISSUE SAMPLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TISSUE SAMPLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL URINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL URINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL URINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MANUAL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MANUAL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MANUAL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SEMI AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SEMI AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SEMI AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FULLY AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTEGRATED WORKCELLS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTEGRATED WORKCELLS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTEGRATED WORKCELLS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TOTAL LABORATORY AUTOMATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TOTAL LABORATORY AUTOMATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TOTAL LABORATORY AUTOMATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL AUTOIMMUNE DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CANCER DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CANCER DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CANCER DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CARDIAC MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CARDIAC MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIABETES MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ACADEMIC & RESEARCH CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL ACADEMIC & RESEARCH CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL ACADEMIC & RESEARCH CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL POINT-OF-CARE TESTING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL POINT-OF-CARE TESTING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL POINT-OF-CARE TESTING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ADULTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PEDIATRICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PEDIATRICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PEDIATRICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 226. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 227. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 228. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 229. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 231. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 232. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 233. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. GCC IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 262. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 263. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 264. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 267. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 268. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 269. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. G7 IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 274. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 275. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 276. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 277. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 279. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 280. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 281. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. NATO IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL IN-VITRO DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 298. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 299. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 300. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 301. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 305. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 306. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. CANADA IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 311. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 312. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 313. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 314. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 316. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 317. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 318. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. MEXICO IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 321. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 323. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 324. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 325. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 326. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 328. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 329. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 330. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 331. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 332. BRAZIL IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 337. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 338. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 340. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 341. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 343. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 344. UNITED KINGDOM IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 346. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 347. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 348. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 349. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 350. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 351. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2032 (USD MILLION)
  • TABLE 352. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY SPECIMEN, 2018-2032 (USD MILLION)
  • TABLE 353. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY WORKFLOW AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 354. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 355. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 356. GERMANY IN-VITRO DIAGNOSTICS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 357. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 358. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 359. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 360. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 361. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY SOFTWARE & INFORMATICS, 2018-2032 (USD MILLION)
  • TABLE 362. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 363. FRANCE IN-VITRO DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY,